Martha Port

4PUBLICATIONS
3CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Health psychologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 16, 2023
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.

Richard B Lipton, Dawn C Buse, Claire H Sandoe

|Jan 25, 2022
Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials.

Jessica Ailani, Dulanji K Kuruppu, Mallikarjuna Rettiganti

|Nov 29, 2020
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.

Janet H Ford, Tobias Kurth, Amaal J Starling

|Jul 26, 2019
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Li Shen Loo, Jessica Ailani, Jack Schim

Pageof 1

Frequent Collaborators

2 joint publications

Janet H Ford

1 joint publications

David W Ayer

1 joint publications

Holland C Detke